British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by Brexit, a damning report warns. Soaring numbers are being diagnosed with the disease amid a growing and ageing population, improved diagnosis initiatives and wider public awareness – making global collaborations to find new medicines essential. But five years after the UK’s exit from the EU, the most comprehensive analysis of its kind concludes that while patients across Europe are benefiting from a golden age of pioneering research and novel treatments, Britons with cancer have
Signing of Trade Agreement Between EU, Mercosur Postponed Until January – Reports
...
Read moreDetails.jpg?width=1200&auto=webp&trim=0%2C175%2C0%2C175&ssl=1 "Historic bridge over Mississippi River set for explosive demolition")
